2,3,4,5-Tetrahydrobenzo[f][1,4]thiazepine → HCID 71548632, compound

HRID 1910444Notes

Reaction equation

HRID 1910444 reaction equation
Cl[C:2]1[N:3]=[C:4](Cl)[C:5]2[S:10][CH:9]=[CH:8][C:6]=2[N:7]=1.[CH:12]1[C:17]2[CH2:18][NH:19][CH2:20][CH2:21][S:22][C:16]=2[CH:15]=[CH:14][CH:13]=1>>[S:22]1[C:16]2[CH:15]=[CH:14][CH:13]=[CH:12][C:17]=2[CH2:18][N:19]([C:2]2[N:3]=[C:4]([NH:3][CH2:4][CH2:5][CH2:6][NH2:7])[C:5]3[S:10][CH:9]=[CH:8][C:6]=3[N:7]=2)[CH2:20][CH2:21]1

Participants

3

Procedure

The title compound was prepared in analogy to Example 1-1 in Scheme 1 by using 2,4-dichlorothieno[3,2-d]pyrimidine and propane-1,3-diamne) and 6,7,8,9-tetrahydro-5-thia-8-aza-benzocycloheptene. MS obsd. (ESI+) [(M+H)+] 372, 1H NMR (400 MHz, METHANOL-d4) δ ppm 7.71 (d, J=5.3 Hz, 1H), 7.65 (d, J=7.1 Hz, 1H), 7.50 (d, J=7.1 Hz, 1H), 7.17-7.25 (m, 1H), 7.10-7.16 (m, 1H), 7.09 (d, J=5.6 Hz, 1H), 5.01 (s, 2H), 4.35 (br. s., 2H), 3.72 (t, J=6.6 Hz, 2H), 2.92-2.96 (m, 2H), 2.87-2.92 (m, 2H), 1.92-2.01 (m, 2H).

Sources & evidence

ORD record
ord-0b556d0f6c184306b50343639459d5b3
Source dataset
uspto-grants-2013_12
Patent number
US08604019B2

Reaction notes

Loading…